A genetic engineering approach that leverages the chloroplast unfolded protein response (cpUPR) pathway to protect plants from abiotic stresses such as heat and drought. Overexpression of key cpUPR genes has been validated in Chlamydomonas, with proposed translation to Arabidopsis and cereal crops to enhance growth, fitness, and carbon sequestration under field stress conditions.
This research opportunity targets the chloroplast unfolded protein response (cpUPR), a cellular pathway that maintains protein and RNA homeostasis inside chloroplasts during environmental stress. By overexpressing key genes within this pathway, plants can be engineered to better withstand abiotic stresses such as heat and drought, leading to improved growth, enhanced crop fitness, and greater carbon sequestration in field conditions.
The approach is grounded in discoveries from a Chlamydomonas mutant screen that identified genes responding to proteotoxicity and chloroplast damage. These genes overlap with networks activated by high light and heat stress, making them promising targets for engineering stress-tolerant crops. The central premise is that protecting chloroplast function during abiotic stress preserves photosynthetic performance and overall plant viability.
The technology is currently at an early-to-mid stage of development. Proof-of-concept validation has been completed in Chlamydomonas, demonstrating that overexpression of a key cpUPR gene provides significant protection against chloroplast stress. The proposed two-year study will advance the work through Arabidopsis transgenic validation under heat and drought stress conditions before translation to cereal crops. This positions the research at a stage suitable for sponsored research collaboration to accelerate gene identification, vector development, and crop translation.
Rutgers University is a comprehensive public research university and New Jersey’s flagship, spanning campuses in New Brunswick–Piscataway, Newark, and Camden. For industry, it offers an integrated clinical and biomedical enterprise through its health system, a statewide extension network for field deployment, and campus-based incubators and pilot-scale facilities that enable prototyping and scale-up. Companies engage through sponsored research, shared core facilities, professional education, and flexible partnership models supported by corporate engagement teams. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, and USDA. A dedicated technology transfer office manages IP, licensing, material transfer, and startup formation, providing clear pathways from lab discovery to market.